{"pmid":32455807,"title":"The COVID-19 Infection in Italy: A Statistical Study of an Abnormally Severe Disease.","text":["The COVID-19 Infection in Italy: A Statistical Study of an Abnormally Severe Disease.","We statistically investigate the Coronavirus Disease 19 (COVID-19) pandemic, which became particularly invasive in Italy in March 2020. We show that the high apparent lethality or case fatality ratio (CFR) observed in Italy, as compared with other countries, is likely biased by a strong underestimation of the number of infection cases. To give a more realistic estimate of the lethality of COVID-19, we use the actual (March 2020) estimates of the infection fatality ratio (IFR) of the pandemic based on the minimum observed CFR and analyze data obtained from the Diamond Princess cruise ship, a good representation of a \"laboratory\" case-study from an isolated system in which all the people have been tested. From such analyses, we derive more realistic estimates of the real extent of the infection as well as more accurate indicators of how fast the infection propagates. We then isolate the dominant factors causing the abnormal severity of the disease in Italy. Finally, we use the death count-the only data estimated to be reliable enough-to predict the total number of people infected and the interval of time when the infection in Italy could end.","J Clin Med","De Natale, Giuseppe","Ricciardi, Valerio","De Luca, Gabriele","De Natale, Dario","Di Meglio, Giovanni","Ferragamo, Antonio","Marchitelli, Vito","Piccolo, Andrea","Scala, Antonio","Somma, Renato","Spina, Emanuele","Troise, Claudia","32455807"],"abstract":["We statistically investigate the Coronavirus Disease 19 (COVID-19) pandemic, which became particularly invasive in Italy in March 2020. We show that the high apparent lethality or case fatality ratio (CFR) observed in Italy, as compared with other countries, is likely biased by a strong underestimation of the number of infection cases. To give a more realistic estimate of the lethality of COVID-19, we use the actual (March 2020) estimates of the infection fatality ratio (IFR) of the pandemic based on the minimum observed CFR and analyze data obtained from the Diamond Princess cruise ship, a good representation of a \"laboratory\" case-study from an isolated system in which all the people have been tested. From such analyses, we derive more realistic estimates of the real extent of the infection as well as more accurate indicators of how fast the infection propagates. We then isolate the dominant factors causing the abnormal severity of the disease in Italy. Finally, we use the death count-the only data estimated to be reliable enough-to predict the total number of people infected and the interval of time when the infection in Italy could end."],"journal":"J Clin Med","authors":["De Natale, Giuseppe","Ricciardi, Valerio","De Luca, Gabriele","De Natale, Dario","Di Meglio, Giovanni","Ferragamo, Antonio","Marchitelli, Vito","Piccolo, Andrea","Scala, Antonio","Somma, Renato","Spina, Emanuele","Troise, Claudia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32455807","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/jcm9051564","keywords":["covid-19","epidemic in italy","statistical forecast"],"locations":["Italy","Italy","Italy","Italy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1667967698883051520,"score":9.490897,"similar":[{"pmid":32234121,"pmcid":"PMC7118348","title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.","text":["Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.","Adjusting for delay from confirmation to death, we estimated case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% (95% confidence interval (CI): 0.89-6.7) and 1.3% (95% CI: 0.38-3.6), respectively. Comparing deaths on board with expected deaths based on naive CFR estimates from China, we estimated CFR and IFR in China to be 1.2% (95% CI: 0.3-2.7) and 0.6% (95% CI: 0.2-1.3), respectively.","Euro Surveill","Russell, Timothy W","Hellewell, Joel","Jarvis, Christopher I","van Zandvoort, Kevin","Abbott, Sam","Ratnayake, Ruwan","Cmmid Covid-Working Group","Flasche, Stefan","Eggo, Rosalind M","Edmunds, W John","Kucharski, Adam J","32234121"],"abstract":["Adjusting for delay from confirmation to death, we estimated case and infection fatality ratios (CFR, IFR) for coronavirus disease (COVID-19) on the Diamond Princess ship as 2.6% (95% confidence interval (CI): 0.89-6.7) and 1.3% (95% CI: 0.38-3.6), respectively. Comparing deaths on board with expected deaths based on naive CFR estimates from China, we estimated CFR and IFR in China to be 1.2% (95% CI: 0.3-2.7) and 0.6% (95% CI: 0.2-1.3), respectively."],"journal":"Euro Surveill","authors":["Russell, Timothy W","Hellewell, Joel","Jarvis, Christopher I","van Zandvoort, Kevin","Abbott, Sam","Ratnayake, Ruwan","Cmmid Covid-Working Group","Flasche, Stefan","Eggo, Rosalind M","Edmunds, W John","Kucharski, Adam J"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234121","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.2807/1560-7917.ES.2020.25.12.2000256","keywords":["covid-19","case fatality ratio","asymptomatic","coronavirus","cruise ship","infection fatality ratio","outbreak","severity"],"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138490304200705,"score":360.01343},{"pmid":32397286,"title":"Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France.","text":["Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France.","The number of screening tests carried out in France and the methodology used to target the patients tested do not allow for a direct computation of the actual number of cases and the infection fatality ratio (IFR). The main objective of this work is to estimate the actual number of people infected with COVID-19 and to deduce the IFR during the observation window in France. We develop a `mechanistic-statistical' approach coupling a SIR epidemiological model describing the unobserved epidemiological dynamics, a probabilistic model describing the data acquisition process and a statistical inference method. The actual number of infected cases in France is probably higher than the observations: we find here a factor x8 (95%-CI: 5-12) which leads to an IFR in France of 0.5% (95%-CI: 0.3-0.8) based on hospital death counting data. Adjusting for the number of deaths in nursing homes, we obtain an IFR of 0.8% (95%-CI: 0.45-1.25). This IFR is consistent with previous findings in China (0.66%) and in the UK (0.9%) and lower than the value previously computed on the Diamond Princess cruse ship data (1.3%).","Biology (Basel)","Roques, Lionel","Klein, Etienne K","Papaix, Julien","Sar, Antoine","Soubeyrand, Samuel","32397286"],"abstract":["The number of screening tests carried out in France and the methodology used to target the patients tested do not allow for a direct computation of the actual number of cases and the infection fatality ratio (IFR). The main objective of this work is to estimate the actual number of people infected with COVID-19 and to deduce the IFR during the observation window in France. We develop a `mechanistic-statistical' approach coupling a SIR epidemiological model describing the unobserved epidemiological dynamics, a probabilistic model describing the data acquisition process and a statistical inference method. The actual number of infected cases in France is probably higher than the observations: we find here a factor x8 (95%-CI: 5-12) which leads to an IFR in France of 0.5% (95%-CI: 0.3-0.8) based on hospital death counting data. Adjusting for the number of deaths in nursing homes, we obtain an IFR of 0.8% (95%-CI: 0.45-1.25). This IFR is consistent with previous findings in China (0.66%) and in the UK (0.9%) and lower than the value previously computed on the Diamond Princess cruse ship data (1.3%)."],"journal":"Biology (Basel)","authors":["Roques, Lionel","Klein, Etienne K","Papaix, Julien","Sar, Antoine","Soubeyrand, Samuel"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397286","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/biology9050097","keywords":["bayesian inference","covid-19","sir model","case fatality rate","infection fatality ratio","mechanistic-statistical model"],"locations":["France","France","France","France","China","GBR","Diamond Princess","France"],"countries":["China","France","United Kingdom"],"countries_codes":["CHN|China","FRA|France","GBR|United Kingdom"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666714494973247488,"score":332.12396},{"pmid":32235086,"title":"As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","text":["As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.","COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities.","J Infect Dev Ctries","Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David","32235086"],"abstract":["COVID-19 case fatalities surged during the month of March 2020 in Italy, reaching over 10,000 by 28 March 2020. This number exceeds the number of fatalities in China (3,301) recorded from January to March, even though the number of diagnosed cases was similar (85,000 Italy vs. 80,000 China). Case Fatality Rates (CFR) could be somewhat unreliable because the estimation of total case numbers is limited by several factors, including insufficient testing and limitations in test kits and materials, such as NP swabs and PPE for testers. Sero prevalence of SARS-CoV-2 antibodies may help in more accurate estimations of the total number of cases. Nevertheless, the disparity in the differences in the total number of fatalities between Italy and China suggests investigation into several factors, such as demographics, sociological interactions, availability of medical equipment (ICU beds and PPE), variants in immune proteins (e.g., HLA, IFNs), past immunity to related CoVs, and mutations in SARS-CoV-2, could impact survival of severe COVID-19 illness survival and the number of case fatalities."],"journal":"J Infect Dev Ctries","authors":["Rubino, Salvatore","Kelvin, Nikki","Bermejo-Martin, Jesus F","Kelvin, David"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235086","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3855/jidc.12734","keywords":["covid-19","case fatality rates","immunity","italy","novel coronavirus","sars-cov-19"],"locations":["Italy","China","Italy","China","Italy","China","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138490327269378,"score":252.8754},{"pmid":32379502,"title":"Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States.","text":["Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States.","Knowing the infection fatality rate (IFR) of SARS-CoV and SARS-CoV-2 infections is essential for the fight against the COVID-19 pandemic. Using data through April 20, 2020, we fit a statistical model to COVID-19 case fatality rates over time at the US county level to estimate the COVID-19 IFR among symptomatic cases (IFR-S) as time goes to infinity. The IFR-S in the US was estimated to be 1.3% (95% central credible interval: 0.6% to 2.1%). County-specific rates varied from 0.5% to 3.6%. The overall IFR for COVID-19 should be lower when we account for cases that remain and recover without symptoms. When used with other estimating approaches, our model and our estimates can help disease and policy modelers to obtain more accurate predictions for the epidemiology of the disease and the impact of alternative policy levers to contain this pandemic. The model could also be used with future epidemics to get an early sense of the magnitude of symptomatic infection at the population-level before more direct estimates are available. Substantial variation across patient demographics likely exists and should be the focus of future studies. [Editor's Note: This Fast Track Ahead Of Print article is the accepted version of the peer-reviewed manuscript. The final edited version will appear in an upcoming issue of Health Affairs.].","Health Aff (Millwood)","Basu, Anirban","32379502"],"abstract":["Knowing the infection fatality rate (IFR) of SARS-CoV and SARS-CoV-2 infections is essential for the fight against the COVID-19 pandemic. Using data through April 20, 2020, we fit a statistical model to COVID-19 case fatality rates over time at the US county level to estimate the COVID-19 IFR among symptomatic cases (IFR-S) as time goes to infinity. The IFR-S in the US was estimated to be 1.3% (95% central credible interval: 0.6% to 2.1%). County-specific rates varied from 0.5% to 3.6%. The overall IFR for COVID-19 should be lower when we account for cases that remain and recover without symptoms. When used with other estimating approaches, our model and our estimates can help disease and policy modelers to obtain more accurate predictions for the epidemiology of the disease and the impact of alternative policy levers to contain this pandemic. The model could also be used with future epidemics to get an early sense of the magnitude of symptomatic infection at the population-level before more direct estimates are available. Substantial variation across patient demographics likely exists and should be the focus of future studies. [Editor's Note: This Fast Track Ahead Of Print article is the accepted version of the peer-reviewed manuscript. The final edited version will appear in an upcoming issue of Health Affairs.]."],"journal":"Health Aff (Millwood)","authors":["Basu, Anirban"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379502","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1377/hlthaff.2020.00455","keywords":["covid-19","case fatality rate","code of federal regulations","comorbidity","diseases","health policy","infection fatality rate","mortality","pandemics","patient testing","populations","coronavirus"],"locations":["US","US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Epidemic Forecasting"],"weight":1,"_version_":1666597097448669184,"score":250.30612},{"pmid":32234343,"pmcid":"PMC7102547","title":"Monitoring Transmissibility and Mortality of COVID-19 in Europe.","text":["Monitoring Transmissibility and Mortality of COVID-19 in Europe.","OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority.","Int J Infect Dis","Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin","32234343"],"abstract":["OBJECTIVES: As a global pandemic is inevitable, real-time monitoring of transmission is vital for containing the spread of COVID-19. The main objective was to report real-time effective reproduction numbers (R(t)) case fatality rate (CFR). METHODS: Data were mainly obtained from WHO website, up to 9 March 2020. R(t) was estimated by exponential growth rate (EG) and time dependent (TD) methods. \"R0\" package in R was employed to estimate R(t) by fitting the existing epidemic curve. Both naive CFR (nCFR) and adjust CFR (aCFR) were estimated. RESULTS: In EG method, R(t) was 3.27 [3.17-3.38] for Italy, 6.32 [5.72-6.99] for France, 6.07 [5.51-6.69] for Germany, 5.08 [4.51-5.74] for Spain. With TD method, the R value for March 9 was 3.10 [2.21-4.11] for Italy, 6.56 [2.04-12.26] for France, 4.43 [1.83-7.92] for Germany, and 3.95 [0-10.19] for Spain. CONCLUSIONS: This study provides important findings on an early outbreak of COVID-19 in Europe. Due to the recent rapid increase in new cases of COVID-19, real-time monitoring of the transmissibility and mortality in Spain and France is a priority."],"journal":"Int J Infect Dis","authors":["Yuan, Jing","Li, Minghui","Lv, Gang","Lu, Z Kevin"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234343","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijid.2020.03.050","keywords":["covid-19","control","europe","effective reproduction numbers"],"locations":["Italy","France","Germany","Spain","Italy","France","Germany","Spain","Spain","France"],"countries":["Italy","Germany","France","Spain"],"countries_codes":["ITA|Italy","DEU|Germany","FRA|France","ESP|Spain"],"topics":["Epidemic Forecasting","Transmission","Prevention"],"weight":1,"_version_":1666138490391232512,"score":242.6671}]}